Back to Journals » OncoTargets and Therapy » Volume 19
let-7d Suppresses Proliferation and Invasion and Promotes Apoptosis of Meningioma by Targeting AEG-1 [Retraction]
Received 5 April 2026
Accepted for publication 5 April 2026
Published 8 April 2026 Volume 2026:19 614704
This retraction applies to:
published online on 06/10/2017Li H, Zhao J. OncoTargets Ther. 2017;10:4895—4904. https://doi.org/10.2147/OTT.S141008
We, the Editors and Publisher of the journal OncoTargets and Therapy, have retracted the published article.
After publication, concerns have been raised by a third party in 2025 about the integrity of the data in Figure 2 of the article.
Further investigation conducted by the Journal and Publisher confirmed unusual similarities present in the image panels representative of different treatment conditions in Figure 2C.
Upon further review, the Journal and Publisher identified additional integrity integrity concerns in the flow cytometry data due to:
Liu Q, Liu H, Cheng HP, Li Y, Li XD, Zhu CY. Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells. Onco Targets Ther. 2017;10:2461-2471. https://doi.org/10.2147/OTT.S124595
Wang B, Ge Z, Cheng Z, Zhao Z. Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL. Biol Open. 2017;6(4):489–495. https://doi.org/10.1242/bio.024133
Liu L, Ren W, Chen K. MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells. Cellular Physiology and Biochemistry. 2017;41(5):1981–1992. https://doi.org/10.1159/000475277
Additional methodological and ethical concerns regarding the human studies were identified.
When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
This retraction relates to this paper
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
